The global sclerotherapy market size is expected to reach USD 1.3 billion by 2027, expanding at a CAGR of 5.6%, according to a new report by Grand View Research, Inc. Sclerotherapy is a non-invasive procedure that is widely used as a primary treatment for reticular veins, leg telangiectasias, and varicose veins. The procedure comprises injecting a solution (sclerosing agents or sclerosants) straight into the affected veins, which causes them to shrink and eventually disappear and assist in treating related symptoms such as aching, burning, swelling, and cramping. Factors like the better exposure to the site of application, utilization of less-invasive technologies, advances in dermatology, and increasing geriatric population with an incidence of varicose veins are fuelling the market growth.
Sclerosing agents used for the treatment of varicose veins are segmented into detergents, hyperosmolar/ osmotic agents, and chemical irritants. Agents like Sodium tetradecyl sulfate (Sotradecol) and Polidocanol (Asclera), Sodium morrhuate (Scleromate), Ethanolamine Oleate (Ethamoline) are all FDA approved sclerosants used to treat and reduce the effect of vein damage. According to the Society of Vascular surgery, more than 33.0% of women and about 17.0% of men consult a doctor for telangiectasias and varicose veins in industrialized countries, affecting up to 35.0% of people in the U.S. alone.
This condition, if left untreated can cause severe health problems such as chronic pain, deep vein clots, skin ulcers, and coronary ailments. According to NCBI, 20.0% of all adults will get varicose veins at some point in their lives and the prevalence is higher among the aging population and women. These factors are expected to boost the market growth. However, the side effects of this procedure such as hyperpigmentation and matting, scarring, and allergic reactions in some patients might hinder the market growth.
Request a Sample Copy of the Sclerotherapy Market Research Report @ https://www.grandviewresearch.com/industry-analysis/sclerotherapy-market/request/rs1
Sclerotherapy Market Report Highlights
- The detergent segment emerged as the largest segment in 2019 owing to high approvals by the FDA, low risk of clot formation, effectiveness, and its popularity among doctors
- The foam sclerotherapy segment is anticipated to grow fast over the forecast period due to better exposure to the onsite and results than liquid sclerotherapy
- North America dominated the market in 2019 owing to increasing demand for new technologies, a large pool of key players, rising prevalence of varicose veins, and advanced healthcare infrastructure in the region
- Asia Pacific is expected to reciprocate the highest CAGR over the forecast period.
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/450829/ibb
Sclerotherapy Market Segmentation
Grand View Research has segmented the global sclerotherapy market on the basis of the agent, type, and region:
Sclerotherapy Agent Outlook (Revenue, USD Million, 2016 – 2027)
- Chemical Irritants
- Osmotic Agents
Sclerotherapy Type Outlook (Revenue, USD Million, 2016 – 2027)
Sclerotherapy Regional Outlook (Revenue, USD Million, 2016 – 2027)
- North America
- The U.S.
- The U.K.
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
List of Key Players of Sclerotherapy Market
- BTG, Kreussler
- LGM Pharma
- ChanganTianyu group
- Bioniche Pharma Group Ltd
- Omega Pharmaceuticals
- Merz Pharma
Browse Related Reports @
Direct Energy Medical Devices Market: https://www.grandviewresearch.com/industry-analysis/direct-energy-medical-devices-market
3D Ultrasound Market: https://www.grandviewresearch.com/industry-analysis/3d-ultrasound-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
Country: United States